| ALLIANCE |
ChemBridge, Pfizer up deal ChemBridge and its ChemBridge Research Laboratories affiliate have extended and expanded a discovery chemistry agreement with Pfizer. The two announced a deal in early 2002 in which some 100 ChemBridge/CRL scientists in the U.S. and Russia would develop combinatorial compound libraries for Pfizer. Under the revised deal, the relationship will be extended from mid-2006 until the end of 2008. In addition, ChemBridge will now offer discovery chemistry, including medicinal chemistry support, to Pfizer. |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |